Skip to Main Content

Advertisement

Skip Nav Destination

FLT3-ITD does not predict inferior prognosis in acute myeloid leukemia patients aged ≥60 years

Blood Adv (2023) 7 (18): 5354–5358.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement